ArticleInternational journal of cancer2021

Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.

Paul G Loftus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.